Duke combines immunotherapy, tumor-roasting nanotech to vaccinate mice against cancer – Durham Herald Sun


Durham Herald Sun
Duke combines immunotherapy, tumor-roasting nanotech to vaccinate mice against cancer
Durham Herald Sun
By combining an FDA-approved cancer immunotherapy with an emerging tumor-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice. The potent combination also attacked ...

More here:

Duke combines immunotherapy, tumor-roasting nanotech to vaccinate mice against cancer - Durham Herald Sun

Related Posts

Comments are closed.